Evidence map›Paper›PMID 33990375›Full record

Observational studyCancer immunology research2021

Mechanisms Driving Neutrophil-Induced T-cell Immunoparalysis in Ovarian Cancer.

Tiffany R Emmons, Thejaswini Giridharan, Kelly L Singel, Anm Nazmul H Khan, Jason Ricciuti, Kaitlyn Howard, Stephanie L Silva-Del Toro, Ivy L Debreceni, Cathelijn E M Aarts, Mieke C Brouwer and 17 more

Open access · bronzeAbstract readObservational Study
In one paragraph

Observational study in Cancer immunology research, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 50 papers.

0numbers the graph read from it
0cells of the map it votes in
50citing papers in PubMed
3.7field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

50 citing papers in PubMed, 69 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Article
  5. Review
  6. Review
  7. Article
  8. Review
  9. Complement system in tumor growth and metastases.British journal of cancer · 2026
    Review
  10. Article
  11. Loss ofOncotarget · 2025
    Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Review
  17. Article
  18. Review
  19. Article
  20. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

27 authors at 9 institutions in 3 countries.

Tiffany R EmmonsDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Thejaswini GiridharanDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Kelly L SingelDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.ORCID 0000-0002-8053-4736
Anm Nazmul H KhanDepartment of Internal Medicine, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Jason RicciutiDepartment of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Kaitlyn HowardDepartment of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-9398-6176
Stephanie L Silva-Del ToroInflammation Program and Immunology Graduate Training Program, University of Iowa, Iowa City, Iowa.ORCID 0000-0002-9036-6289
Ivy L DebreceniInflammation Program and Immunology Graduate Training Program, University of Iowa, Iowa City, Iowa.
Cathelijn E M AartsDepartment of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0001-8440-4632
Mieke C BrouwerDepartment of Immunopathology, Sanquin Research, Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.
Sora SuzukiDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Taco W KuijpersDepartment of Blood Cell Research, Sanquin Research and Landsteiner Laboratory, Academic Medical Center (AMC), University of Amsterdam, Amsterdam, the Netherlands.
Ilse JongeriusDepartment of Immunopathology, Sanquin Research, Landsteiner Laboratory, Amsterdam UMC, University of Amsterdam, Amsterdam, the Netherlands.ORCID 0000-0002-7759-9897
Lee-Ann H AllenInflammation Program, Departments of Medicine and Microbiology and Immunology, University of Iowa, Iowa City, Iowa.ORCID 0000-0001-8929-6968
Viviana P FerreiraDepartment of Medical Microbiology and Immunology, University of Toledo College of Medicine and Life Sciences, Toledo, Ohio.ORCID 0000-0001-8923-5671
Anna SchubartNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Holger SellnerNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Jörg EderNovartis Institutes for BioMedical Research, Novartis Campus, Basel, Switzerland.
Steven M HollandLaboratory of Clinical Infectious Diseases, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, Maryland.ORCID 0000-0003-3207-5464
Sanjay RamDivision of Infectious Diseases and Immunology, Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts.
James A LedererDepartment of Surgery, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.ORCID 0000-0002-6445-252X
Kevin H EngDepartment of Biostatistics and Bioinformatics, Roswell Park Comprehensive Cancer Center, Buffalo, New York.ORCID 0000-0001-5636-0812
Kirsten B MoysichDepartment of Cancer Prevention and Control, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Kunle OdunsiDepartment of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Michael B YaffeCenter for Precision Cancer Medicine, Departments of Biological Engineering and Biology, Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts.ORCID 0000-0002-9547-3251
Emese ZsirosDepartment of Gynecologic Oncology, Roswell Park Comprehensive Cancer Center, Buffalo, New York.
Brahm H SegalDepartment of Immunology, Roswell Park Comprehensive Cancer Center, Buffalo, New York. brahm.segal@roswellpark.org.ORCID 0000-0001-5043-7380
Roswell Park Comprehensive Cancer Center · USSanquin · NLNovartis (Switzerland) · CHUniversity of Iowa · USBrigham and Women's Hospital · USBeth Israel Deaconess Medical Center · USNational Institute of Allergy and Infectious Diseases · USUniversity of Massachusetts Chan Medical School · USUniversity of Toledo Medical Center · US

Funding

Two-Spirit Films in Indigenous Cancer HealthP30CA016056 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI Dean G. Tang · 1985 to 2026
$116.6M
Novel immunological biomarkers ovarian cancer prognosisR01CA188900 · NCI · ROSWELL PARK CANCER INSTITUTE CORP · PI MOYSICH, KIRSTEN B., SEGAL, BRAHM H. · 2015 to 2019
$3.3M
Therapy of acute radiation syndrome and its complications by mesenchymal stromal cells conditioned with Toll-like receptor 9 agonistsU01AI138318 · NIAID · BRIGHAM AND WOMEN'S HOSPITAL · PI LEDERER, JAMES A., PERRELLA, MARK A · 2018 to 2022
$3.1M
Neutrophil Plasticity and H. pylori PathogenesisR01AI119965 · NIAID · UNIVERSITY OF MISSOURI-COLUMBIA · PI ALLEN, LEE-ANN H · 2016 to 2020
$2.1M
Imaging Flow CytometerS10OD018048 · OD · ROSWELL PARK CANCER INSTITUTE CORP · PI MINDERMAN, HANS · 2014 to 2014
$400k
NCI NIH HHS P30 CA016056NCI NIH HHS R01 CA188900NIAID NIH HHS R01 AI119965NIAID NIH HHS U01 AI138318NIH HHS S10 OD018048
6 · The paper itself

Abstract

T-cell activation and expansion in the tumor microenvironment (TME) are critical for antitumor immunity. Neutrophils in the TME acquire a complement-dependent T-cell suppressor phenotype that is characterized by inhibition of T-cell proliferation and activation through mechanisms distinct from those of myeloid-derived suppressor cells. In this study, we used ascites fluid supernatants (ASC) from patients with ovarian cancer as an authentic component of the TME to evaluate the effects of ASC on neutrophil function and mechanisms for neutrophil-driven immune suppression. ASC prolonged neutrophil life span, decreased neutrophil density, and induced nuclear hypersegmentation. Mass cytometry analysis showed that ASC induced 15 distinct neutrophil clusters. ASC stimulated complement deposition and signaling in neutrophils, resulting in surface mobilization of granule constituents, including NADPH oxidase. NADPH oxidase activation and phosphatidylserine signaling were required for neutrophil suppressor function, although we did not observe a direct role of extracellular reactive oxygen species in inhibiting T-cell proliferation. Postoperative surgical drainage fluid also induced a complement-dependent neutrophil suppressor phenotype, pointing to this effect as a general response to injury. Like circulating lymphocytes, ASC-activated neutrophils caused complement-dependent suppression of tumor-associated lymphocytes. ASC-activated neutrophils adhered to T cells and caused trogocytosis of T-cell membranes. These injury and signaling cues resulted in T-cell immunoparalysis characterized by impaired NFAT translocation, IL2 production, glucose uptake, mitochondrial function, and mTOR activation. Our results demonstrate that complement-dependent priming of neutrophil effector functions in the TME induces a T-cell nonresponsiveness distinct from established checkpoint pathways and identify targets for immunotherapy.

Indexed as

Tumor EscapeAdultCells, CulturedFemaleHumansLymphocyte ActivationMiddle AgedNeutrophil ActivationNeutrophilsOvarian NeoplasmsPrimary Cell CultureT-LymphocytesTrogocytosisTumor MicroenvironmentYoung Adult

Identifiers

PMID33990375
PMCPMC8287091
OpenAlexW3161229587

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.